
-
CORPORATE - 26-03-2018
Human Rabies - An Interview with Peter J. Costa MPH
Rabies Immune Globulin Brand Director at Kedrion Biopharma
read more -
CORPORATE - 12-02-2018
Global Maternal Health Milestone Reached: 50th Anniversary
U.S. Approval of RhoGAM®, Rho(D) Immune Globulin
read more -
EVENTS - 14-12-2017
KEDRAB™: Pivotal Phase 2/3 Data presented at RITA Conference
Kedrion Biopharma and Kamada Received FDA Approval of the Product in Q3 2017
read more -
CORPORATE - 25-08-2017
Kedrion Biopharma and Kamada Receive FDA Approval of KEDRAB™
For Post-Exposure Prophylaxis Against Rabies Infection
read more
Pages
For more information please contact: pressoffice@kedrion.com